Short Bowel Syndrome Global Market Report 2025

Published Jun 17, 2025

Length 175 Pages

SKU # BRC20111167

Description

Short Bowel Syndrome Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on short bowel syndrome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for short bowel syndrome ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The short bowel syndrome market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Glucagon-Like Peptide (GLP-2); Growth Hormone; Glutamine

2) By Diagnosis: Physical Exam; Blood Tests; Fecal Fat Tests; Imaging Procedures; Other Diagnosis

3) By Treatment: Nutritional Therapy; Medications; Surgery; Transplant

4) By Distribution Channel: Hospital Pharmacies; Specialty Pharmacies; Other Distribution Channels

Subsegments:

1) By Glucagon-Like Peptide (GLP-2): Teduglutide; Other GLP-2 Analogues

2) By Growth Hormone: Somatropin; Other Growth Hormone Therapies

3) By Glutamine: Oral Glutamine; Intravenous Glutamine

Companies Mentioned: Nestlé SA; Pfizer Inc; Johnson & Johnson; Sanofi SA; Nutrinia

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

1. Executive Summary
2. Short Bowel Syndrome Market Characteristics
3. Short Bowel Syndrome Market Trends And Strategies
4. Short Bowel Syndrome Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Short Bowel Syndrome Growth Analysis And Strategic Analysis Framework: 5.1. Global Short Bowel Syndrome PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints); 5.2. Analysis Of End Use Industries; 5.3. Global Short Bowel Syndrome Market Growth Rate Analysis; 5.4. Global Short Bowel Syndrome Historic Market Size and Growth, 2019 - 2024, Value ($ Billion); 5.5. Global Short Bowel Syndrome Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion); 5.6. Global Short Bowel Syndrome Total Addressable Market (TAM)
6. Short Bowel Syndrome Market Segmentation: 6.1. Global Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Glucagon-Like Peptide (GLP-2); Growth Hormone; Glutamine; 6.2. Global Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Physical Exam; Blood Tests; Fecal Fat Tests; Imaging Procedures; Other Diagnosis; 6.3. Global Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Nutritional Therapy; Medications; Surgery; Transplant; 6.4. Global Short Bowel Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Hospital Pharmacies; Specialty Pharmacies; Other Distribution Channels; 6.5. Global Short Bowel Syndrome Market, Sub-Segmentation Of (Glucagon-Like Peptide) GLP-2, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Teduglutide; Other GLP-2 Analogues; 6.6. Global Short Bowel Syndrome Market, Sub-Segmentation Of Growth Hormone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Somatropin; Other Growth Hormone Therapies; 6.7. Global Short Bowel Syndrome Market, Sub-Segmentation Of Glutamine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Oral Glutamine; Intravenous Glutamine
7. Short Bowel Syndrome Market Regional And Country Analysis: 7.1. Global Short Bowel Syndrome Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 7.2. Global Short Bowel Syndrome Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Short Bowel Syndrome Market: 8.1. Asia-Pacific Short Bowel Syndrome Market Overview; Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies; 8.2. Asia-Pacific Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 8.3. Asia-Pacific Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 8.4. Asia-Pacific Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Short Bowel Syndrome Market: 9.1. China Short Bowel Syndrome Market Overview; 9.2. China Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion; 9.3. China Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion; 9.4. China Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Short Bowel Syndrome Market: 10.1. India Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 10.2. India Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 10.3. India Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Short Bowel Syndrome Market: 11.1. Japan Short Bowel Syndrome Market Overview; 11.2. Japan Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 11.3. Japan Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 11.4. Japan Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Short Bowel Syndrome Market: 12.1. Australia Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 12.2. Australia Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 12.3. Australia Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Short Bowel Syndrome Market: 13.1. Indonesia Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 13.2. Indonesia Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 13.3. Indonesia Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Short Bowel Syndrome Market: 14.1. South Korea Short Bowel Syndrome Market Overview; 14.2. South Korea Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 14.3. South Korea Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 14.4. South Korea Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Short Bowel Syndrome Market: 15.1. Western Europe Short Bowel Syndrome Market Overview; 15.2. Western Europe Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 15.3. Western Europe Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 15.4. Western Europe Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Short Bowel Syndrome Market: 16.1. UK Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 16.2. UK Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 16.3. UK Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Short Bowel Syndrome Market: 17.1. Germany Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 17.2. Germany Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 17.3. Germany Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Short Bowel Syndrome Market: 18.1. France Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 18.2. France Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 18.3. France Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Short Bowel Syndrome Market: 19.1. Italy Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 19.2. Italy Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 19.3. Italy Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Short Bowel Syndrome Market: 20.1. Spain Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 20.2. Spain Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 20.3. Spain Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Short Bowel Syndrome Market: 21.1. Eastern Europe Short Bowel Syndrome Market Overview; 21.2. Eastern Europe Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 21.3. Eastern Europe Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 21.4. Eastern Europe Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Short Bowel Syndrome Market: 22.1. Russia Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 22.2. Russia Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 22.3. Russia Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Short Bowel Syndrome Market: 23.1. North America Short Bowel Syndrome Market Overview; 23.2. North America Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 23.3. North America Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 23.4. North America Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Short Bowel Syndrome Market: 24.1. USA Short Bowel Syndrome Market Overview; 24.2. USA Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 24.3. USA Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 24.4. USA Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Short Bowel Syndrome Market: 25.1. Canada Short Bowel Syndrome Market Overview; 25.2. Canada Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 25.3. Canada Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 25.4. Canada Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Short Bowel Syndrome Market: 26.1. South America Short Bowel Syndrome Market Overview; 26.2. South America Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 26.3. South America Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 26.4. South America Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Short Bowel Syndrome Market: 27.1. Brazil Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 27.2. Brazil Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 27.3. Brazil Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Short Bowel Syndrome Market: 28.1. Middle East Short Bowel Syndrome Market Overview; 28.2. Middle East Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 28.3. Middle East Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 28.4. Middle East Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Short Bowel Syndrome Market: 29.1. Africa Short Bowel Syndrome Market Overview; 29.2. Africa Short Bowel Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 29.3. Africa Short Bowel Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 29.4. Africa Short Bowel Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Short Bowel Syndrome Market Competitive Landscape And Company Profiles: 30.1. Short Bowel Syndrome Market Competitive Landscape; 30.2. Short Bowel Syndrome Market Company Profiles; 30.2.1. Nestlé SA Overview, Products and Services, Strategy and Financial Analysis; 30.2.2. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis; 30.2.3. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis; 30.2.4. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis; 30.2.5. Nutrinia Overview, Products and Services, Strategy and Financial Analysis
31. Short Bowel Syndrome Market Other Major And Innovative Companies: 31.1. GlaxoSmithKline plc; 31.2. Takeda Pharmaceutical Company Limited; 31.3. Zealand Pharma; 31.4. Baxter International Inc.; 31.5. Alnylam Pharmaceuticals; 31.6. OPKO Health Inc; 31.7. Ironwood Pharmaceuticals Inc.; 31.8. Hanmi Pharm Co. Ltd; 31.9. Ardelyx Inc; 31.10. Emmaus Life Sciences Inc; 31.11. Jaguar Health; 31.12. 9 Meters Biopharma Inc.; 31.13. OxThera Inc.; 31.14. Adocia SAS; 31.15. EnteraBio Ltd
32. Global Short Bowel Syndrome Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Short Bowel Syndrome Market
34. Recent Developments In The Short Bowel Syndrome Market
35. Short Bowel Syndrome Market High Potential Countries, Segments and Strategies: 35.1 Short Bowel Syndrome Market In 2029 - Countries Offering Most New Opportunities; 35.2 Short Bowel Syndrome Market In 2029 - Segments Offering Most New Opportunities; 35.3 Short Bowel Syndrome Market In 2029 - Growth Strategies; 35.3.1 Market Trend Based Strategies; 35.3.2 Competitor Strategies
36. Appendix: 36.1. Abbreviations; 36.2. Currencies; 36.3. Historic And Forecast Inflation Rates; 36.4. Research Inquiries; 36.5. The Business Research Company; 36.6. Copyright And Disclaimer

Pricing

Currency Rates

Single User Email from Publisher $4,490
Site License Fulfilled by Publisher $6,490
Global Site License Email from Publisher $8,490

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now